ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1581

Differential Involvement of Synovial and Entheseal Inflammation in Mediating Pathological IL23 Axis Signaling in Spondyloarthritis

Ed Purdue1, Josselyn Galdamez1, Madeline Epsten2, Rima Abhyankar3, Kathleen Hoyt4, Michelle Lewis4, Devan Dove4, Jon Hill5, Alexander Klimowicz4, Gerald Nabozny6, Joseph Wahle4 and Lisa A. Mandl7, 1Research, Hospital for Special Surgery, New York, NY, 2Rheumatology, Hospital for Special Surgery, New York, NY, 3Hospital for Special Surgery, New York, NY, 4Department of Immunology and respiratory discovery research, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, 5Department of Discovery research, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, 6[email protected], Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, 7Rheumatology, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: IL-23, macrophages and spondylarthritis, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Spondyloarthropathies and Psoriatic Arthritis – Pathogenesis, Etiology Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Although accumulating evidence continues to point toward a critical role for IL23 signaling in spondyloarthritis (SpA), the cellular and molecular events involved, as well as the respective contributions of enthesial and synovial inflammation, remain incompletely understood. In this study we have combined ex vivo organ culture of enthesial and synovial explants from SpA patients and controls with in-situ hybridization (ISH) and gene expression analysis of synovial tissue to further delineate the molecular and cellular pathogenesis underlying SpA.

Methods: Under an HSS IRB approved protocol, patients undergoing total hip replacement (THR) were recruited into 3 groups: SpA (either psoriatic arthritis or ankylosing spondylitis, meeting ASAS or CASPAR criteria or were being treated with DMARDS/biologics); HO (OA patients a previous contralateral THR who had history of post-THR heterotopic ossification) and OA (OA patients a previous contralateral THR with no history of HO. For Phase 1 of this study (n=15/group), synovial tissue was collected intra-operatively and immediately aliquoted into RNAlater for RNA isolation and subsequent sequencing, or OCT for ISH analysis. For Phase 2 (n=10/group), entheseal tissue (ligamentum teres) and synovial tissue were cultured +/- RORgT inhibitor (2 hours) followed by +/- cytokine stimulation (hTNF/hIL23) for 24 and 48 hours. These cultures were analyzed via MSD for secreted cytokines and via TaqMan RT-PCR.

Results:

RNA sequencing identified the presence of a macrophage signature with elevation of MMPs and MARCO in SpA tissue. Additionally preliminary ISH analysis has shown a potential enrichment of CD163 positive macrophages in areas of synovial inflammation. Expression analysis of ALI cultured explants also identified a remarkable enrichment of MARCO-positive macrophages in synovium (cf enthesis) and, consistent with the RNA sequencing of whole tissue, induction of MMP production in synovium following cytokine stimulation. In contrast entheseal tissue that had a lower MMP and MARCO signature, responded to cytokine stimulation with induction of IL17A/F and IFNg. Importantly, this latter effect was most pronounced in SpA patients and inhibited by an ROR inhibitor.

Conclusion:

Our results suggest that the synovial and entheseal tissues in SpA patients have distinct cellular phenotypes and differential responses to cytokines and involvement of RORgt signaling. In line with previous observations (refs) a prominent macrophage signature is seen in the synovium, and this is associated with elevation of MMP induction in SpA. Whereas entheseal tissue produced IL17 and IFNg in response to TNF and IL23, consistent with the presence of a resident population of IL23R positive T cells at this site in SpA.


Disclosure: E. Purdue, Boehringer Ingelheim Pharmaceuticals, 2; J. Galdamez, None; M. Epsten, None; R. Abhyankar, None; K. Hoyt, Boehringer Ingelheim Pharmaceuticals Inc, 3; M. Lewis, Boehringer Ingelheim Pharmaceuticals Inc, 3; D. Dove, Boehringer Ingelheim Pharmaceuticals Inc, 3; J. Hill, Boehringer Ingelheim Pharmaceuticals nc, 3; A. Klimowicz, Boehringer Ingelheim Pharmaceuticals Inc, 3; G. Nabozny, Boehringer Ingelheim, 3; J. Wahle, Boehringer Ingelheim Pharmaceuticals Inc, 3; L. A. Mandl, Boehringer Ingelheim, 2,American College of Physicians, 3,Up To Date, 7.

To cite this abstract in AMA style:

Purdue E, Galdamez J, Epsten M, Abhyankar R, Hoyt K, Lewis M, Dove D, Hill J, Klimowicz A, Nabozny G, Wahle J, Mandl LA. Differential Involvement of Synovial and Entheseal Inflammation in Mediating Pathological IL23 Axis Signaling in Spondyloarthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/differential-involvement-of-synovial-and-entheseal-inflammation-in-mediating-pathological-il23-axis-signaling-in-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/differential-involvement-of-synovial-and-entheseal-inflammation-in-mediating-pathological-il23-axis-signaling-in-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology